Pharmacokinetics of Single Ascending Doses of the P-Glycoprotein Inhibitor Tariquidar in Healthy Subjects

Publisher： Karger

E-ISSN： 1423-0313|91|1-2|12-19

ISSN： 0031-7012

Source： Pharmacology, Vol.91, Iss.1-2, 2012-11, pp. : 12-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Silibinin, Inhibitor of CYP3A4 and P-Glycoprotein in vitro, on the Pharmacokinetics of Paclitaxel after Oral and Intravenous Administration in Rats

By  

Pharmacology, Vol. 85, Iss. 6, 2010-06 ,pp. : 350-356

Karger

Access to resources Recommend Favorite

Marine Natural Products with P-Glycoprotein Inhibitor Properties

By Lopez Dioxelis   Martinez-Luis Sergio  

Marine Drugs, Vol. 12, Iss. 1, 2014-01 ,pp. : 525-546

MDPI

Access to resources Recommend Favorite

Effects of Phytochemical P-Glycoprotein Modulators on the Pharmacokinetics and Tissue Distribution of Doxorubicin in Mice

By Kim Tae Hwan   Shin Soyoung   Yoo Sun Dong   Shin Beom Soo  

Molecules, Vol. 23, Iss. 2, 2018-02 ,pp. : 349-349

MDPI

Access to resources Recommend Favorite

Single-Dose Pharmacokinetics of the Renin Inhibitor ACT-077825 in Elderly and Young Subjects of Both Sexes

By  

Pharmacology, Vol. 94, Iss. 3-4, 2014-09 ,pp. : 135-142

Karger

Access to resources Recommend Favorite

Vincristine-Induced Neuropathy in the Rat Is Not Modified by Drug-Drug Interactions with the P-Glycoprotein Inhibitor Verapamil

By  

Chemotherapy, Vol. 54, Iss. 5, 2008-08 ,pp. : 336-342

Karger

Access to resources Recommend Favorite